These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 31092279)

  • 1. Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.
    Siedlecki-Wullich D; Català-Solsona J; Fábregas C; Hernández I; Clarimon J; Lleó A; Boada M; Saura CA; Rodríguez-Álvarez J; Miñano-Molina AJ
    Alzheimers Res Ther; 2019 May; 11(1):46. PubMed ID: 31092279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia.
    Piscopo P; Grasso M; Puopolo M; D'Acunto E; Talarico G; Crestini A; Gasparini M; Campopiano R; Gambardella S; Castellano AE; Bruno G; Denti MA; Confaloni A
    J Alzheimers Dis; 2018; 65(2):455-464. PubMed ID: 30056425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
    Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
    J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
    Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
    Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
    Kumar S; Vijayan M; Reddy PH
    Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease.
    Dakterzada F; Targa A; Benítez ID; Romero-ElKhayat L; de Gonzalo-Calvo D; Torres G; Moncusí-Moix A; Huerto R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G
    Alzheimers Res Ther; 2020 Dec; 12(1):163. PubMed ID: 33278902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
    De Felice B; Montanino C; Oliva M; Bonavita S; Di Onofrio V; Coppola C
    Mol Neurobiol; 2020 Nov; 57(11):4408-4416. PubMed ID: 32737762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
    Dong H; Li J; Huang L; Chen X; Li D; Wang T; Hu C; Xu J; Zhang C; Zen K; Xiao S; Yan Q; Wang C; Zhang CY
    Dis Markers; 2015; 2015():625659. PubMed ID: 26078483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer's Disease at the Prodromal Stage.
    He H; Liu A; Zhang W; Yang H; Zhang M; Xu H; Liu Y; Hong B; Yan F; Yue L; Wang J; Xiao S; Xie Z; Wang T
    J Alzheimers Dis; 2021; 83(2):779-790. PubMed ID: 34366343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
    Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
    Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma microRNA biomarkers for detection of mild cognitive impairment.
    Sheinerman KS; Tsivinsky VG; Crawford F; Mullan MJ; Abdullah L; Umansky SR
    Aging (Albany NY); 2012 Sep; 4(9):590-605. PubMed ID: 23001356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond CSF and Neuroimaging Assessment: Evaluating Plasma miR-145-5p as a Potential Biomarker for Mild Cognitive Impairment and Alzheimer's Disease.
    Wen Q; Wittens MMJ; Engelborghs S; van Herwijnen MHM; Tsamou M; Roggen E; Smeets B; Krauskopf J; Briedé JJ
    ACS Chem Neurosci; 2024 Mar; 15(5):1042-1054. PubMed ID: 38407050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease.
    Ansari A; Maffioletti E; Milanesi E; Marizzoni M; Frisoni GB; Blin O; Richardson JC; Bordet R; Forloni G; Gennarelli M; Bocchio-Chiavetto L;
    Neurobiol Aging; 2019 Oct; 82():102-109. PubMed ID: 31437718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiRNA -483-5p as a Potential Noninvasive Biomarker for Early Detection of Alzheimer's Disease.
    Sabry R; El Sharkawy RE; Gad NM
    Egypt J Immunol; 2020 Jun; 27(2):59-72. PubMed ID: 33548978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
    Tan L; Yu JT; Tan MS; Liu QY; Wang HF; Zhang W; Jiang T; Tan L
    J Alzheimers Dis; 2014; 40(4):1017-27. PubMed ID: 24577456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miR-206 and miR-132 as Potential Circulating Biomarkers for Mild Cognitive Impairment.
    Xie B; Zhou H; Zhang R; Song M; Yu L; Wang L; Liu Z; Zhang Q; Cui D; Wang X; Xu S
    J Alzheimers Dis; 2015; 45(3):721-31. PubMed ID: 25589731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miRNAs as potential biomarkers in Alzheimer's disease.
    Galimberti D; Villa C; Fenoglio C; Serpente M; Ghezzi L; Cioffi SM; Arighi A; Fumagalli G; Scarpini E
    J Alzheimers Dis; 2014; 42(4):1261-7. PubMed ID: 25024331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulatory miR-223-3p Discriminates Between Parkinson's and Alzheimer's Patients.
    Mancuso R; Agostini S; Hernis A; Zanzottera M; Bianchi A; Clerici M
    Sci Rep; 2019 Jun; 9(1):9393. PubMed ID: 31253822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower Serum Levels of miR-29c-3p and miR-19b-3p as Biomarkers for Alzheimer's Disease.
    Wu Y; Xu J; Xu J; Cheng J; Jiao D; Zhou C; Dai Y; Chen Q
    Tohoku J Exp Med; 2017 Jun; 242(2):129-136. PubMed ID: 28626163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of Pathogenic Proteins and MicroRNAs in Plasma-derived Extracellular Vesicles in Alzheimer's Disease: A Pilot Study.
    Li F; Xie XY; Sui XF; Wang P; Chen Z; Zhang JB
    Neuroscience; 2020 Apr; 432():240-246. PubMed ID: 32135232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.